Stockscreener 앱 받기
1.75
1.74%
0.03
전일 마감가:
$1.72
열려 있는:
$1.72
하루 거래량:
65,738
Relative Volume:
0.59
시가총액:
$82.44M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.57%
1개월 성능:
-12.06%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.6699
$1.84
1주일 범위
$1.6699
$1.84
52주 변동 폭
$1.39
$2.20
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
명칭
Whitehawk Therapeutics Inc
전화
551-321-2234
주소
2 HEADQUARTERS PLAZA, MORRISTOWN
WHWK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
1.75 | 84.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | 개시 | Jefferies | Buy |
| 2021-10-01 | 개시 | Cowen | Outperform |
| 2021-09-14 | 개시 | Ladenburg Thalmann | Buy |
| 2021-09-08 | 개시 | Piper Sandler | Overweight |
모두보기
Whitehawk Therapeutics Inc 주식(WHWK)의 최신 뉴스
How to track smart money flows in Whitehawk Therapeutics Inc.Asset Growth Pattern and Return Summary - Newser
Detecting support and resistance levels for Whitehawk Therapeutics Inc.Real Time Stock Movement and Alerts - Newser
Whitehawk Therapeutics Inc. stock daily chart insightsFree Triple Digit Return Stock Predictions - Newser
Whitehawk Therapeutics (NASDAQ:WHWK) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Has Whitehawk Therapeutics Inc. found a price floorFree Growth Focused Entry Plan Suggestions - Newser
Whitehawk Therapeutics Inc. stock volume spike explainedTrade Ideas Based on Fundamental Metrics - Newser
How Whitehawk Therapeutics Inc. stock performs during market volatilityReversal Pattern Insights with Entry Tips - Newser
What institutional flow reveals about Whitehawk Therapeutics Inc.Momentum Prediction Based on AI Backtesting - Newser
What momentum shifts mean for Whitehawk Therapeutics Inc.ROI Focused Watchlist with Trade Confidence - Newser
What makes Whitehawk Therapeutics Inc. stock price move sharplyLow Drawdown Picks with Weekly Updates - Newser
Published on: 2025-08-09 02:18:04 - Newser
Whitehawk Therapeutics (NASDAQ:WHWK) Downgraded to “Strong Sell” Rating by Wall Street Zen - Defense World
Heatmap analysis for Whitehawk Therapeutics Inc. and competitorsShort-Term Profit Alert With Entry Forecast - Newser
Full technical analysis of Whitehawk Therapeutics Inc. stockSwing Candidate List with Trade Cues - Newser
What earnings revisions data tells us about Whitehawk Therapeutics Inc.Technical Long-Term Outlook and Recap Guide - Newser
Whitehawk Therapeutics Advances ADC Portfolio Amid Financial Growth - TipRanks
Technical analysis overview for Whitehawk Therapeutics Inc. stockFree Swing Setup With Technical Confirmation - Newser
Whitehawk Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Whitehawk Therapeutics earnings missed by $1.01, revenue was in line with estimates - Investing.com Canada
Whitehawk Therapeutics Reports Q2 GAAP EPS of -$0.76, Cash Reserves Reach $177.2 Million - AInvest
Whitehawk Therapeutics Triples Cash Reserves to $177M, Fast-Tracks Three Cancer Drug Programs - Stock Titan
Pattern recognition hints at Whitehawk Therapeutics Inc. upsideMomentum-Based Prediction for Quick Returns - Newser
Forecasting Whitehawk Therapeutics Inc. price range with options dataInsider Strategy for High Conviction Picks - Newser
Developing predictive dashboards with Whitehawk Therapeutics Inc. dataShort-Term Price Breakout Signal Analysis - Newser
Using RSI to spot recovery in Whitehawk Therapeutics Inc.Breakout Monitoring with Momentum Analysis - Newser
What MACD and RSI say about Whitehawk Therapeutics Inc.Pattern Breakout Prediction for Short Term - Newser
What are the latest earnings results for Whitehawk Therapeutics Inc.Unlock your trading potential with expert tips - Jammu Links News
How strong is Whitehawk Therapeutics Inc. company’s balance sheetGet alerts on the hottest stocks daily - Jammu Links News
What analysts say about Whitehawk Therapeutics Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Whitehawk Therapeutics Inc. a good long term investmentUnlock exclusive trading strategies for gains - Jammu Links News
What institutional investors are buying Whitehawk Therapeutics Inc. stockUnlock powerful trading signals for profits - Jammu Links News
Price action breakdown for Whitehawk Therapeutics Inc.Long Hold Investment Strategy with Growth Focus - Newser
Backtesting results for Whitehawk Therapeutics Inc. trading strategiesReal-Time Investment Signal Forecast with AI - Newser
Should I hold or sell Whitehawk Therapeutics Inc. stock in 2025Invest smarter with data-backed insights - Jammu Links News
Why is Whitehawk Therapeutics Inc. stock attracting strong analyst attentionDiscover high-impact investment opportunities - Jammu Links News
How does Whitehawk Therapeutics Inc. generate profit in a changing economyAchieve consistent double-digit growth rates - Jammu Links News
Is Whitehawk Therapeutics Inc. a growth stock or a value stockMaximize returns with smart investment plans - Jammu Links News
Whitehawk Therapeutics Inc (WHWK) 재무 분석
Whitehawk Therapeutics Inc (WHWK)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):